Zentalis Pharmaceuticals Dirección
Dirección controles de criterios 0/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Julie Eastland
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | no data |
| Participación del CEO | n/a |
| Permanencia media de la dirección | less than a year |
| Promedio de permanencia en la Junta Directiva | 2yrs |
Actualizaciones recientes de la dirección
Recent updates
We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Needs To Drive Business Growth Carefully
Oct 03
Broker Revenue Forecasts For Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Are Surging Higher
Jun 19We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Jun 13Results: Zentalis Pharmaceuticals, Inc. Confounded Analyst Expectations With A Surprise Profit
May 09Zentalis Pharmaceuticals: Data In 1st Half Of 2024 Could Get The Ball Rolling
Apr 12We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Can Afford To Drive Business Growth
Feb 29Zentalis: Leading WEE1 Developer After AstraZeneca's Exit
Feb 05Is Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Trading At A 45% Discount?
Jan 09We're Not Very Worried About Zentalis Pharmaceuticals' (NASDAQ:ZNTL) Cash Burn Rate
Oct 13We Think Zentalis Pharmaceuticals (NASDAQ:ZNTL) Can Afford To Drive Business Growth
Jun 30We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Mar 17We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Dec 01Zentalis Pharmaceuticals promotes co-founder Kevin Bunker to chief scientific officer
Sep 27Zentalis Pharmaceuticals has a new chief medical officer
Sep 19Zentalis Pharmaceuticals (NASDAQ:ZNTL) Is In A Good Position To Deliver On Growth Plans
Aug 17Here's Why We're Not Too Worried About Zentalis Pharmaceuticals' (NASDAQ:ZNTL) Cash Burn Situation
May 02We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Jan 12We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Oct 14Companies Like Zentalis Pharmaceuticals (NASDAQ:ZNTL) Are In A Position To Invest In Growth
Jul 02Have Insiders Sold Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Recently?
Mar 08Companies Like Zentalis Pharmaceuticals (NASDAQ:ZNTL) Are In A Position To Invest In Growth
Jan 20CEO
Julie Eastland (60 yo)
no data
Permanencia
Ms. Julie M. Eastland is CEO, President & Director of Zentalis Pharmaceuticals, Inc. from November 12, 2024. Ms. Eastland joined the Zentalis Pharmaceuticals, Inc. on November 12, 2024. She serves as Indep...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chief Legal Officer & Corporate Secretary | 2.3yrs | US$2.63m | 0.0097% $ 21.9k | |
| CEO, President & Director | no data | sin datos | sin datos | |
| VP of Finance & Interim Principal Accounting Officer | less than a year | sin datos | 0.048% $ 107.7k | |
| Chief Scientific Officer | less than a year | sin datos | 0.0035% $ 7.9k | |
| Chief Strategy Officer | 1.3yrs | sin datos | sin datos | |
| Chief Business Officer | less than a year | sin datos | sin datos | |
| Chief Medical Officer | no data | sin datos | sin datos |
0.8yrs
Permanencia media
46.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de ZNTL no se considera experimentado ( 0.8 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | no data | sin datos | sin datos | |
| Chairman of the Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 2.2yrs | US$515.22k | 0.067% $ 152.5k | |
| Independent Director | 4.8yrs | US$617.78k | 0.20% $ 459.2k | |
| Director | less than a year | sin datos | sin datos | |
| Independent Director | 3.8yrs | US$516.97k | 0.054% $ 121.4k | |
| Independent Director | 6.9yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 1.8yrs | sin datos | sin datos |
2.0yrs
Permanencia media
54yo
Promedio de edad
Junta con experiencia: La junta directiva de ZNTL no se considera experimentada (2 años de permanencia promedio), lo que sugiere una nueva junta directiva.